FR2602680B1 - PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION - Google Patents

PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION

Info

Publication number
FR2602680B1
FR2602680B1 FR8711402A FR8711402A FR2602680B1 FR 2602680 B1 FR2602680 B1 FR 2602680B1 FR 8711402 A FR8711402 A FR 8711402A FR 8711402 A FR8711402 A FR 8711402A FR 2602680 B1 FR2602680 B1 FR 2602680B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
nasal administration
nasal
administration
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR8711402A
Other languages
French (fr)
Other versions
FR2602680A1 (en
Inventor
Moise Azria
Thomas Cavanak
Andreas Rummelt
Wolfgang Doepfner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868620035A external-priority patent/GB8620035D0/en
Priority claimed from GB868626821A external-priority patent/GB8626821D0/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2602680A1 publication Critical patent/FR2602680A1/en
Application granted granted Critical
Publication of FR2602680B1 publication Critical patent/FR2602680B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
FR8711402A 1986-08-18 1987-08-10 PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION Expired - Fee Related FR2602680B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868620035A GB8620035D0 (en) 1986-08-18 1986-08-18 Organic compounds
GB868626821A GB8626821D0 (en) 1986-11-10 1986-11-10 Organic compounds

Publications (2)

Publication Number Publication Date
FR2602680A1 FR2602680A1 (en) 1988-02-19
FR2602680B1 true FR2602680B1 (en) 1993-04-16

Family

ID=26291187

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8711402A Expired - Fee Related FR2602680B1 (en) 1986-08-18 1987-08-10 PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION

Country Status (24)

Country Link
KR (1) KR880002537A (en)
AT (1) AT396331B (en)
AU (2) AU612589B2 (en)
BE (1) BE1001748A4 (en)
CA (1) CA1322331C (en)
CH (1) CH672252A5 (en)
CS (1) CS411491A3 (en)
DE (1) DE3726517A1 (en)
DK (1) DK428287A (en)
ES (1) ES2004807A6 (en)
FI (1) FI93307C (en)
FR (1) FR2602680B1 (en)
GR (1) GR871289B (en)
HK (1) HK80493A (en)
HU (1) HU200940B (en)
IE (1) IE60761B1 (en)
IL (1) IL83572A (en)
IT (1) IT1222510B (en)
LU (1) LU86971A1 (en)
NL (1) NL8701874A (en)
NO (1) NO175519C (en)
NZ (1) NZ221473A (en)
PT (1) PT85545B (en)
SE (1) SE8703183L (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110034381A1 (en) 2002-01-22 2011-02-10 David Kleinberg Methods for Therapeutic Treatment of Benign Prostatic Hypertrophy (BPH)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034925B2 (en) * 1979-07-31 1985-08-12 帝人株式会社 Long-acting nasal preparation and its manufacturing method
CY1327A (en) * 1979-11-27 1986-06-27 Sandoz Ag Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use
US4451394A (en) * 1982-10-25 1984-05-29 American Home Products Corporation Dodecapeptides preventing glucose and triglyceride assimilation
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
US4505897A (en) * 1983-04-18 1985-03-19 The Administrators Of The Tulane Educational Fund Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
JPS60224616A (en) * 1984-04-24 1985-11-09 Teijin Ltd Composition for administration through nose
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
JPH085913B2 (en) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド Therapeutic somatostatin congeners

Also Published As

Publication number Publication date
NL8701874A (en) 1988-03-16
IL83572A (en) 1992-09-06
NO873452D0 (en) 1987-08-17
NO175519B (en) 1994-07-18
LU86971A1 (en) 1988-03-02
GR871289B (en) 1987-12-18
BE1001748A4 (en) 1990-02-27
FI873548A (en) 1988-02-19
AU637530B2 (en) 1993-05-27
DE3726517A1 (en) 1988-03-03
NZ221473A (en) 1990-08-28
SE8703183D0 (en) 1987-08-17
DK428287D0 (en) 1987-08-17
AU8568991A (en) 1991-12-05
IE60761B1 (en) 1994-08-10
KR880002537A (en) 1988-05-09
AT396331B (en) 1993-08-25
DK428287A (en) 1988-02-19
IL83572A0 (en) 1988-01-31
FI873548A0 (en) 1987-08-17
FI93307C (en) 1995-03-27
IT1222510B (en) 1990-09-05
CH672252A5 (en) 1989-11-15
IT8721670A0 (en) 1987-08-18
FR2602680A1 (en) 1988-02-19
HU200940B (en) 1990-09-28
PT85545A (en) 1987-09-01
HK80493A (en) 1993-08-13
HUT46235A (en) 1988-10-28
CA1322331C (en) 1993-09-21
IE872187L (en) 1988-02-18
NO175519C (en) 1994-10-26
AU612589B2 (en) 1991-07-18
ATA206087A (en) 1992-12-15
ES2004807A6 (en) 1989-02-01
PT85545B (en) 1990-05-31
AU7712087A (en) 1988-02-25
CS411491A3 (en) 1992-06-17
SE8703183L (en) 1988-02-19
FI93307B (en) 1994-12-15
NO873452L (en) 1988-02-19

Similar Documents

Publication Publication Date Title
DZ1077A1 (en) New pharmaceutical preparation for oral administration.
BE849632A (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
FR2523443B1 (en) NOVEL PHARMACEUTICAL FORMULATIONS CONTAINING COENZYME Q10 SUITABLE FOR TOPICAL ADMINISTRATION
ITRM910696A0 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL APPLICATION.
FR2582513B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ALFUZOSINE
FR2508318B1 (en) BANDAGE FOR THE ADMINISTRATION OF A PHARMACEUTICAL SUBSTANCE
FR2565829B1 (en) DEVICE FOR THE ADMINISTRATION OF DRUGS IN THE FORM OF POWDERS
PT87492A (en) PROCESS FOR THE PREPARATION OF BENZO] B "PYRRANS AND PYRANOPYRIDINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1246188B (en) PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS HAVING INCREASED SPEED OF DISSOLUTION OF THE ACTIVE SUBSTANCE AND COMPOSITIONS OBTAINED.
FR2629716B1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION BASED ON A DIPHOSPHONIC ACID DERIVATIVE
BE845613A (en) PHARMACEUTICAL PREPARATIONS FOR ORAL ADMINISTRATION CONTAINING NANDROLONE ESTER-17BETA AND NEW NANDROLONE ESTERS-17BETA
FR2611501B1 (en) NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ROUTE BASED ON LYSINE ACETYLSALIELYLATE AND PROCESS FOR OBTAINING SAME
FR2688405B1 (en) PROCESS FOR THE PREPARATION OF A STABLE MEDICINAL SOLUTION FOR ORAL CONTROLLED RELEASE, BASED ON A BETA-BLOCKER, AND PHARMACEUTICAL COMPOSITION BASED ON A BETA-BLOCKER.
FR2754177B1 (en) PHARMACEUTICAL MICROSPHERES OF VALPROIC ACID FOR ORAL ADMINISTRATION
FR2480603B1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING CYTIDINE-DIPHOSPHOCHOLINE
FR2568773B1 (en) NEW NASAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITIONS
IT9019112A1 (en) PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR THE ORAL ADMINISTRATION OF CALCITONIN
FR2587216B1 (en) PHARMACEUTICAL COMPOSITION BASED ON HUMAN ERYTHROPOIETIN FOR NASAL ADMINISTRATION FOR THE TREATMENT OF ANEMIA
BE902796A (en) ESTER OF ACETYL CARNITINE, ITS PREPARATION AND ITS USE.
FR2660192B1 (en) LIPOSOMIAL FORMULATION FOR TOPICAL OR VAGINAL ADMINISTRATION OF DRUGS.
MC1878A1 (en) PHARMACEUTICAL COMPOSITIONS
FR2602680B1 (en) PHARMACEUTICAL COMPOSITIONS FOR NASAL ADMINISTRATION
IT1223132B (en) PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION
ITMI913510A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH BIOAVAILABILITY PROGESTERONE
FR2585953B1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION CONTAINING UBIQUINONE AND METHOD

Legal Events

Date Code Title Description
ST Notification of lapse